Discovery by NIAID-funded researchers could aid quest for universal flu vaccine. The ever-changing “head” of an influenza virus protein has an unexpected Achilles heel, report scientists funded by the National Institute...
Early mutation in neutralizing antibody gives it flexibility to adapt to virus’s changes In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region...
A single infusion of a powerful antibody called VRC01 can suppress the level of HIV in the blood of infected people who are not taking antiretroviral therapy (ART), scientists at the National Institutes of Health report...
The first self-injectable HIV antibody, PRO 140, has a 98 percent success rate in reducing the virus in HIV patients’ blood, according to results released from a Phase 2b clinical trial of the drug. PRO 140 works by...
Results from a new trial found that an “extremely potent” antibody can dramatically reduce the level of the HIV virus in a patient’s blood — raising hopes for an HIV vaccine. Researchers at Rockefeller...
Researchers have identified a powerful antibody which requires a minute amount to neutralise the dengue virus, paving the way for effective treatment of the mosquito-borne infection. A new study showed how a newly...
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute, for the first time have shown how human antibodies can neutralize the Marburg virus, a close...